Literature DB >> 17701211

Epithelial-mesenchymal transition (EMT) of renal tubular cells in canine glomerulonephritis.

Luca Aresu1, Maria Pia Rastaldi, Eugenio Scanziani, James Baily, Enrico Radaelli, Paola Pregel, Federico Valenza.   

Abstract

Tubulo-interstitial fibrosis in dogs may result from primary injury to the interstitium or develop secondary to other renal diseases. As in human renal pathology, tubular epithelial cells (TEC) are believed to actively participate in the mechanisms of renal fibrosis. In this study, we examined the changes in the tubular epithelial component in two specific canine diseases. Immunohistochemistry showed the expression of the epithelial marker cytokeratin, the smooth muscle marker alpha-SMA, the mesenchymal marker vimentin and PCNA in 20 dogs with membranous glomerulonephritis and membrano-proliferative glomerulonephritis. Results showed that the loss of the epithelial marker in TEC was directly correlated to the grade of tubulo-interstitial disease present and independent of the type of glomerulonephritis. Varying degrees of vimentin positivity were detected in tubular epithelium in areas of inflammation, and low numbers of scattered alpha-SMA-positive cells were also observed. Immunohistochemistry showed that epithelial tubular cells lose their cytokeratin staining characteristics and transdifferentiate into cells exhibiting key mesenchymal immunophenotypic feature of vimentin-positive staining in both diseases investigated. The integrity of the tubular basement membrane is likely to be fundamental in maintaining the epithelial phenotype of TEC. Animal models provide opportunities for investigating the pathogenesis of renal fibrosis in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17701211     DOI: 10.1007/s00428-007-0482-8

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  23 in total

Review 1.  Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention.

Authors:  Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2004-01       Impact factor: 10.121

2.  Differential immunoexpressions of cytoskeletons in renal epithelial and interstitial cells in rat and canine fibrotic kidneys, and in kidney-related cell lines under fibrogenic stimuli.

Authors:  Jyoji Yamate; Masanori Kuribayashi; Mitsuru Kuwamura; Takao Kotani; Kikumi Ogihara
Journal:  Exp Toxicol Pathol       Date:  2005-08-15

Review 3.  Epithelial origin of myofibroblasts during fibrosis in the lung.

Authors:  Brigham C Willis; Roland M duBois; Zea Borok
Journal:  Proc Am Thorac Soc       Date:  2006-06

4.  Tumor promoter-induced disruption of junctional complexes in cultured epithelial cells is followed by the inhibition of cytokeratin and desmoplakin synthesis.

Authors:  A Ben-Ze'ev
Journal:  Exp Cell Res       Date:  1986-06       Impact factor: 3.905

5.  Renal tubular basement membrane changes in tubulointerstitial damage in patients with glomerular diseases.

Authors:  R Sinniah; T N Khan
Journal:  Ultrastruct Pathol       Date:  1999 Nov-Dec       Impact factor: 1.094

6.  Expression of vimentin in the tubular epithelium of bovine kidneys with interstitial nephritis.

Authors:  E Scanziani; V Grieco; S Salvi
Journal:  Vet Pathol       Date:  1993-05       Impact factor: 2.221

7.  Role of atrophic tubules in development of interstitial fibrosis in microembolism-induced renal failure in rat.

Authors:  T Suzuki; M Kimura; M Asano; Y Fujigaki; A Hishida
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

8.  Evidence that fibroblasts derive from epithelium during tissue fibrosis.

Authors:  Masayuki Iwano; David Plieth; Theodore M Danoff; Chengsen Xue; Hirokazu Okada; Eric G Neilson
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

9.  Expression of class II major histocompatibility complex molecules in renal tubular epithelial cells of canine kidneys affected with tubulointerstitial nephritis.

Authors:  M Vilafranca; P Wohlsein; G Trautwein
Journal:  Res Vet Sci       Date:  1995-09       Impact factor: 2.534

Review 10.  Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure.

Authors:  Masaomi Nangaku
Journal:  Intern Med       Date:  2004-01       Impact factor: 1.271

View more
  6 in total

Review 1.  New insights into epithelial-mesenchymal transition in kidney fibrosis.

Authors:  Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 10.121

2.  Differential expression of proteoglycans in tissue remodeling and lymphangiogenesis after experimental renal transplantation in rats.

Authors:  Heleen Rienstra; Kirankumar Katta; Johanna W A M Celie; Harry van Goor; Gerjan Navis; Jacob van den Born; Jan-Luuk Hillebrands
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

3.  Dog as model for down-expression of E-cadherin and beta-catenin in tubular epithelial cells in renal fibrosis.

Authors:  Luca Aresu; Maria Pia Rastaldi; Paola Pregel; Federico Valenza; Enrico Radaelli; Eugenio Scanziani; Massimo Castagnaro
Journal:  Virchows Arch       Date:  2008-10-24       Impact factor: 4.064

4.  Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis.

Authors:  Keizo Kanasaki; Gangadhar Taduri; Daisuke Koya
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-06       Impact factor: 5.555

5.  MicroRNA-590 is an EMT-suppressive microRNA involved in the TGFβ signaling pathway.

Authors:  Tianming Liu; Fang Nie; Xianggui Yang; Xiaoyan Wang; Yue Yuan; Zhongshi Lv; Li Zhou; Rui Peng; Dongsheng Ni; Yuping Gu; Qin Zhou; Yaguang Weng
Journal:  Mol Med Rep       Date:  2015-09-25       Impact factor: 2.952

6.  Histological and immunohistochemical characterization of feline renal cell carcinoma: a case series.

Authors:  Federico Bonsembiante; Silvia Lucia Benali; Davide Trez; Luca Aresu; Maria Elena Gelain
Journal:  J Vet Med Sci       Date:  2016-02-18       Impact factor: 1.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.